Clinical Trial Update: The DART DELIVER-02 Study [Phase 1]

View source ↗

Summary

DART DELIVER-02 is a Phase 1 clinical trial sponsored by the University of North Carolina, Chapel Hill, and is currently recruiting for an HIV-related intervent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV (Human Immunodeficiency Virus) | Phase 1 | Status: RECRUITING